$TRVI
Trevi Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$13.98
▲After hours+0.00%+$0.000After hours
Trevi Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is TRVI up today? It is at $13.98 (+0.90%), and our scanner flagged it 118 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TRVI spikes, and full due diligence on TRVI — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $TRVI 118 times in the last 30 days. Create a free account to track $TRVI, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
TRVI is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 3 unusual-volume and momentum alerts on TRVI today, peaking at 10.8x its normal volume.
Likely catalystTrevi Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedOct 27, 2026 · 8 days agoThe company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $13/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Heffernan Michael Thomas Director | Sold (automatic/other) | -39K 0.03% of company | sold 86% | 6K | $596K at $15.09 | Sep 15, 26 |
Heffernan Michael Thomas Director | Other | 39K 0.03% of company | n/a | 27K | $120K at $3.04 | Sep 15, 26 |
Galletta Christopher Officer | Other | 4K | added 19% | 26K | $2K at $0.510 | Dec 2, 25 |
Sciascia Thomas Officer | Sold (automatic/other) | -3K | sold 1.2% | 221K | $17K at $6.60 | Mar 25, 25 |
Sciascia Thomas Officer | Other | 3K | added 1.2% | 224K | $4K at $1.43 | Mar 25, 25 |
Good Jennifer L Officer | Sold (automatic/other) | -5K | sold 2.4% | 213K | $35K at $6.58 | Mar 21, 25 |
Good Jennifer L Officer | Other | 5K | added 2.5% | 219K | $8K at $1.43 | Mar 21, 25 |
Simon Farrell Officer | Sold (automatic/other) | -81K 0.06% of company | sold 51% | 77K | $547K at $6.73 | Mar 10, 25 |
Simon Farrell Officer | Other | 113K 0.08% of company | added 100% | 158K | $57K at $0.510 | Mar 10, 25 |
Delfini Lisa Officer | Other | 5K | added 8.4% | 65K | $3K at $0.510 | Jan 8, 25 |
Delfini Lisa Officer | Other | 1K | added 1.7% | 60K | $510 at $0.510 | Jan 7, 25 |
Galletta Christopher Officer | Other | 15K 0.01% of company | added 100% | 20K | $8K at $0.510 | Dec 13, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
TRVI is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 3 unusual-volume and momentum alerts on TRVI today, peaking at 10.8x its normal volume.
TRVI last traded at $13.98, up 0.90% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Trevi Therapeutics, Inc. Common Stock (TRVI) is next expected to report earnings on Thursday, November 12, 2026, about 8 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The TRVI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TRVI 118 times in the last 30 days.
TRVI (Trevi Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $1.97B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TRVI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$TRVI discussion
Sign in to ask a question or join the discussion.